Education
About Us
Working with TipRanks
Follow Us
Beijing Tong Ren Tang Chinese Medicine Co (HK:3613)
:3613
RESEARCH TOOLSreports
Total Valuation
Beijing Tong Ren Tang Chinese Medicine Co has a market cap or net worth of HK$7.26B. The enterprise value is HK$7.71B.
Market CapHK$7.26B
Enterprise ValueHK$7.71B
Share Statistics
Beijing Tong Ren Tang Chinese Medicine Co has 837,100,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding837,100,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Beijing Tong Ren Tang Chinese Medicine Co’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 11.06%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.11
Return on Invested Capital (ROIC)11.06%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee2.06M
Profits Per Employee639.74K
Employee Count782
Asset Turnover0.35
Inventory Turnover0.34
Valuation Ratios
The current PE Ratio of Beijing Tong Ren Tang Chinese Medicine Co is 14.69. Beijing Tong Ren Tang Chinese Medicine Co’s PEG ratio is 2.71.
PE Ratio14.69
PS Ratio0.00
PB Ratio2.66
Price to Fair Value1.80
Price to FCF18.85
Price to Operating Cash Flow17.52
PEG Ratio2.71
Income Statement
In the last 12 months, Beijing Tong Ren Tang Chinese Medicine Co had revenue of 1.61B and earned 500.28M in profits. Earnings per share was 0.60.
Revenue1.61B
Gross Profit1.07B
Operating Income576.92M
Pretax Income629.77M
Net Income500.28M
EBITDA722.32M
Earnings Per Share (EPS)0.60
Cash Flow
In the last 12 months, operating cash flow was -303.86M and capital expenditures -11.22M, giving a free cash flow of -315.07M billion.
Operating Cash Flow-303.86M
Free Cash Flow-315.07M
Free Cash Flow per Share-0.38
Dividends & Yields
Beijing Tong Ren Tang Chinese Medicine Co pays an annual dividend of HK$0.349, resulting in a dividend yield of 4.04%
Dividend Per ShareHK$0.349
Dividend Yield4.04%
Payout Ratio58.66%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.79
52-Week Price Change-3.25%
50-Day Moving Average8.33
200-Day Moving Average8.02
Relative Strength Index (RSI)59.45
Average Volume (3m)1.00M
Important Dates
Beijing Tong Ren Tang Chinese Medicine Co upcoming earnings date is Aug 8, 2025, TBA Not Confirmed.
Last Earnings DateMar 28, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend DateJun 05, 2025
Financial Position
Beijing Tong Ren Tang Chinese Medicine Co as a current ratio of 16.85, with Debt / Equity ratio of 2.86%
Current Ratio16.85
Quick Ratio10.10
Debt to Market Cap<0.01
Net Debt to EBITDA-2.28
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Beijing Tong Ren Tang Chinese Medicine Co has paid 100.61M in taxes.
Income Tax100.61M
Effective Tax Rate0.16
Enterprise Valuation
Beijing Tong Ren Tang Chinese Medicine Co EV to EBITDA ratio is 7.89, with an EV/FCF ratio of 0.00.
EV to Sales3.54
EV to EBITDA7.89
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Beijing Tong Ren Tang Chinese Medicine Co has HK$1.83B in cash and marketable securities with HK$123.42M in debt, giving a net cash position of -HK$1.71B billion.
Cash & Marketable SecuritiesHK$1.83B
Total DebtHK$123.42M
Net Cash-HK$1.71B
Net Cash Per Share-HK$2.04
Tangible Book Value Per ShareHK$4.99
Margins
Gross margin is 66.44%, with operating margin of 35.80%, and net profit margin of 31.04%.
Gross Margin66.44%
Operating Margin35.80%
Pretax Margin39.08%
Net Profit Margin31.04%
EBITDA Margin44.82%
EBIT Margin39.48%
Analyst Forecast
The average price target for Beijing Tong Ren Tang Chinese Medicine Co is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast5.69%
EPS Growth Forecast-7.43%